Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). In: 20th Annual British Thoracic Oncology Group Conference 2022, 27-28 Jan 2022, Virtual.
Metadata
Item Type: | Conference or Workshop Item |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2022, Elsevier. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/. This is an author produced version of a conference abstract published in Lung Cancer. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Biotechnology; Health Disparities; Lung Cancer; Minority Health; Lung; Cancer; Radiation Oncology; Radiotherapy and other non-invasive therapies; Radiotherapy and other non-invasive therapies; Cancer |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology |
Funding Information: | Funder Grant number Cancer Research UK Supplier No: 138573 C43923/A28890 |
Depositing User: | Symplectic Publications |
Date Deposited: | 14 Aug 2024 10:00 |
Last Modified: | 15 Aug 2024 13:59 |
Published Version: | https://www.sciencedirect.com/science/article/pii/... |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/s0169-5002(22)00200-8 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:216105 |